Vimarsana
Biggest News Aggregation in the World

Page 2 - Andre Esteva News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Andre Esteva. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Andre Esteva Today - Breaking & Trending Today

Startups Are Using AI to Predict Responses to Cancer Drugs - Vimarsana News

Startups Are Using AI to Predict Responses to Cancer Drugs

More accurate prognoses and treatments tailored to patients—entrepreneurs claim AI can be harnessed for breakthroughs in beating cancer. One founder is using lab-grown human organs in combination with AI to test drug efficacy.

Artificial intelligence experts share 6 of the biggest AI innovations of 2023 - Vimarsana News

Artificial intelligence experts share 6 of the biggest AI innovations of 2023

Widely regarded as the breakout year for AI, 2023 ushered in a whole crop of new and improved tech tools for health care. These are a few of the biggest innovations.

Artificial intelligence experts share 6 of the biggest AI innovations of 2023: 'A landmark year' - Vimarsana News

Artificial intelligence experts share 6 of the biggest AI innovations of 2023: 'A landmark year'

From cancer care to communications, here’s where AI moved the needle in health care

Source: yahoo.com
ArteraAI and GenesisCare Partner to Provide Precision Cancer Therapy to Patients with Localized Prostate Cancer In Australia - Vimarsana News

ArteraAI and GenesisCare Partner to Provide Precision Cancer Therapy to Patients with Localized Prostate Cancer In Australia

Patients treated at GenesisCare clinics in Australia can work with clinicians to access AI-based decision making tools as part of a new clinical trial

ArteraAI and GenesisCare Partner to Launch the First Australian-Based Clinical Trial - Vimarsana News

ArteraAI and GenesisCare Partner to Launch the First Australian-Based Clinical Trial

SAN FRANCISCO & SYDNEY--(BUSINESS WIRE)--ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and prognostic cancer tools, today announced a strategic collaborative